-
ACCURACY AND EFFICIENCY OF A HUMAN-IN-THE-LOOP PROMPT-FEEDBACK WORKFLOW FOR ARTIFICIAL INTELLIGENCE-ENABLED EVIDENCE SYNTHESIS: A MULTIPLE MYELOMA SYSTEMATIC LITERATURE REVIEW CASE STUDY
Aug 11, 2026, 17:16 PM -
IDENTIFICATION AND USE OF PROGNOSTIC FACTORS AND TREATMENT EFFECT MODIFIERS IN NICE TECHNOLOGY APPRAISALS: DIFFERENCES BETWEEN ONCOLOGY AND RARE DISEASES AND IMPLICATIONS FOR JCA
Aug 11, 2026, 17:16 PM -
PATIENT-REPORTED OUTCOMES AMONG COMMUNITY MENTAL HEALTH SERVICE USERS
Aug 11, 2026, 17:16 PM -
EFFICIENCY GAPS IN SUBCUTANEOUS BIOLOGIC THERAPY: A REAL-WORLD DATA ENVELOPMENT ANALYSIS
Aug 11, 2026, 17:16 PM -
CALCIFEDIOL VERSUS CHOLECALCIFEROL IN HYPOVITAMINOSIS D: A REGIONAL COST ANALYSIS IN SPAIN
Aug 11, 2026, 17:16 PM -
THE BURDEN OF PROGRESSIVE SUPRANUCLEAR PALSY AND CORTICOBASAL DEGENERATION: FINDINGS FROM A PSPA PATIENT AND CAREGIVER SURVEY IN THE UNITED KINGDOM
Aug 11, 2026, 17:16 PM -
UTILISATION OF INHALED THERAPIES FOR MAINTENANCE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN IRELAND: A RETROSPECTIVE ANALYSIS OF PRIMARY CARE CLAIMS DATA
Aug 11, 2026, 17:16 PM -
CONFIDENTIAL YET ACCOUNTABLE? PROTECTING COMMERCIAL DATA WHILE KEEPING EU HTA TRANSPARENT
Aug 11, 2026, 17:16 PM -
COMPARATIVE HEALTHCARE BURDEN OF MASH AND NON-ALCOHOLIC CIRRHOSIS: EVIDENCE FROM AN ITALIAN REAL-WORLD ADMINISTRATIVE DATABASE
Aug 11, 2026, 17:16 PM -
WHAT DOES GOOD LOOK LIKE? POLICY RECOMMENDATIONS FOR ADVANCING THE ACCEPTANCE OF RWE IN REGULATORY AND HTA DECISION-MAKING
Aug 11, 2026, 17:16 PM -
USING EARLY ECONOMIC EVALUATION TO IDENTIFY VALUE DRIVERS FOR ALGORITHM-GUIDED TREATMENT ALLOCATION IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC): A HYBRID DECISION TREE-PARTITIONED SURVIVAL FRAMEWORK
Aug 11, 2026, 17:16 PM -
THE IMPACT OF SEMAGLUTIDE ON HOSPITALIZATION AND HEALTHCARE COSTS IN ISRAEL
Aug 11, 2026, 17:16 PM -
ASSOCIATION BETWEEN ADDED THERAPEUTIC VALUE AND COST-EFFECTIVENESS OF ONCOLOGY MEDICINES ACROSS FIVE EUROPEAN HTA SYSTEMS
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF OBESITY: REAL-WORLD DATA FROM THE GREEK PRIVATE HEALTHCARE SECTOR
Aug 11, 2026, 17:16 PM -
QUANTIFYING THE SOCIETAL VALUE OF RESMETIROM FOR METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS USING A SOCIETAL VALUE MODELING APPROACH
Aug 11, 2026, 17:16 PM -
ANNUAL ECONOMIC BURDEN OF STROKE IN PATIENTS WITH TYPE 2 DIABETES IN TURKIYE: A PUBLIC PAYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
OPEN-WEIGHT LLMS RUN LOCALLY MATCH AND SOMETIMES BEAT FRONTIER MODELS FOR SYSTEMATIC AND TARGETED LITERATURE REVIEW ABSTRACT SCREENING
Aug 11, 2026, 17:16 PM -
CLINICAL TRIAL EVIDENCE, EXPEDITED REGULATORY PATHWAYS, AND REVIEW EFFICIENCY OF RARE DISEASE DRUGS APPROVED IN CHINA, 2016-2025
Aug 11, 2026, 17:16 PM -
REAL-WORLD CORTICOSTEROID BURDEN REDUCTION WITH SUBCUTANEOUS IMMUNOGLOBULIN IGPRO20 IN CIDP
Aug 11, 2026, 17:16 PM -
EVALUATING THE ECONOMIC AND ORGANIZATIONAL IMPACT OF SUBCUTANEOUS OCRELIZUMAB FOR MULTIPLE SCLEROSIS IN ALGERIA
Aug 11, 2026, 17:16 PM
